£
Donate

We're here for you if you want to talk

0808 2080 888

[email protected]

Our impact

Over 60 years, we've invested more than £500 million in blood cancer research which has led to a long line of breakthroughs that have improved treatments and saved lives.

Together we’ve achieved an incredible amount in the last 60 years, but there’s still much more to be done before we see a day where blood cancer is finally beaten.

We believe that if we continue funding research at the same pace as we have been for the last 60 years, in the next 30 years, we’ll be in a position to ensure there are more effective treatments for every type of blood cancer. We can beat them all!

Susan and David Eastwood 600x600.jpg

Our impact in leukaemia

Many of the leading doctors in the 1960s and 1970s, who looked into finding cures for leukaemia, were either directly funded by us or played a crucial role on our scientific advisory board.

Framed photo of Hugo, in remission from childhood leukaemia

Our impact in childhood leukaemia

Tackling childhood leukaemia was the main area of focus for our founders and is where we have some of our biggest research breakthroughs

Doctor and young woman talking

Our impact in myeloma

Our research in myeloma has helped pioneer new treatments and improve existing ones.

RS175_iStock-538888108 younger man lymph nodes checking (HL booklet 2018).jpg

Our impact in lymphoma

Our research in lymphoma has focused on improving treatments.

Two researchers look through microscopes side by side in a lab.

Our impact across all blood cancers and beyond

We’ve invested in lab research, resources and people.

A female doctor counsels a patient

How our research helps other types of cancers

Our investment in blood cancer research has provided crucial understanding of how cancers develop as well as tests and treatments. Some of this learning has helped people with other types of cancer and other diseases.

Our discoveries

Read about sixty years of discoveries our researchers have made that have had a positive impact on the lives of people with blood cancer.

Read more